Journal article
Spatial transcriptomics reveals a key role of fibroblast-like vascular smooth muscle cells in human atherosclerotic cell crosstalk and stability
- Abstract:
- Background and Aims: Atherosclerotic plaques are the leading cause of cardiovascular events. Single-cell approaches have identified diverse human plaque cell phenotypes but their spatial distribution and interactions remain unclear. Here, intercellular communication patterns in human plaque microenvironments were mapped to reveal novel targets to prevent atherosclerotic events. Methods: Spatial transcriptomics (Visium, 10x) from 13 carotid plaques, and single-cell transcriptomics (cells = 51 981) were used to analyse cell phenotypes, cell trajectories, and intercellular communications. Cells contributing to plaque stability were explored using deconvolution of plaque bulk RNA-seq data (n = 78), histology, and survival analyses. Key cells and pathways were validated in apolipoprotein E (Apoe)−/− mice and in vitro. Genome-wide association study enrichment analyses were conducted using summary statistics of atherosclerotic diseases. LINCS L1000 data were used to explore drug repurposing. Results: A fibroblast-like vascular smooth muscle cell (VSMC) phenotype associated with extracellular matrix formation pathways (validated in Apoe−/− mice) emerged as a key regulator of intra-plaque ligand-receptor signalling, in particular in the cap region. A higher proportion of fibroblast-like VSMCs was found in asymptomatics, associated with stable plaque features and predicted a lower risk of future events. Genes specific to this VSMC phenotype were enriched in coronary artery disease and myocardial infarction. Finally, compounds, which could induce key marker genes were identified and validated in vitro. Conclusions: This study provides the first comprehensive spatial transcriptomics map of cell communication in human plaque microenvironments. A pivotal role of a fibroblast-like VSMC, orchestrating intraplaque cell signalling and contributing to plaque stability, was identified. Targeting these cells might present promising novel avenues for therapies.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 18.3MB, Terms of use)
-
- Publisher copy:
- 10.1093/eurheartj/ehaf1091
Authors
+ Swedish Heart Lung Foundation
More from this funder
- Funder identifier:
- 10.13039/501100003793
- Grant:
- 20220044
+ Swedish Foundation for Strategic Research
More from this funder
- Funder identifier:
- https://ror.org/044wr7g58
- Grant:
- Dnr IRC15-0067
+ Swedish Research Council
More from this funder
- Funder identifier:
- https://ror.org/03zttf063
- Grant:
- 2019-01260
+ Swedish Society for Medical Research
More from this funder
- Funder identifier:
- https://ror.org/0433fd238
- Grant:
- CG-22-0254-H-02
+ Swedish Stroke Association
More from this funder
- Funder identifier:
- https://ror.org/02pqxz266
- Grant:
- S-993166
- Publisher:
- Oxford University Press
- Journal:
- European Heart Journal More from this journal
- Article number:
- ehaf1091
- Publication date:
- 2026-02-13
- Acceptance date:
- 2025-12-18
- DOI:
- EISSN:
-
1522-9645
- ISSN:
-
0195668X, 0195-668X
- Language:
-
English
- Keywords:
- Source identifiers:
-
3756733
- Deposit date:
-
2026-02-13
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record